Published in J Immunol on February 20, 2012
WRB and CAML are necessary and sufficient to mediate tail-anchored protein targeting to the ER membrane. PLoS One (2014) 0.93
CAML mediates survival of Myc-induced lymphoma cells independent of tail-anchored protein insertion. Cell Death Discov (2017) 0.79
Yet another hump for CAML: support of cell survival independent of tail-anchored protein insertion. Cell Death Dis (2017) 0.75
Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol (2002) 13.87
Lymphocyte homing and homeostasis. Science (1996) 13.26
Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med (1991) 10.87
In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell (1997) 7.18
An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science (2001) 5.73
B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res (1997) 5.43
BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science (2001) 4.79
B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med (1999) 4.52
Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med (1985) 4.16
Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol (2001) 3.92
BAFF: a fundamental survival factor for B cells. Nat Rev Immunol (2002) 2.94
NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science (1997) 2.75
Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med (2001) 2.57
Normal structure, function, and histology of the spleen. Toxicol Pathol (2006) 2.50
A developmental switch in B lymphopoiesis. Proc Natl Acad Sci U S A (1991) 1.96
c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity (2005) 1.87
Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. Nature (1994) 1.71
Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J Immunol (2004) 1.53
Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. J Immunol (1996) 1.40
Intracellular Ca2+ signals activate apoptosis in thymocytes: studies using the Ca(2+)-ATPase inhibitor thapsigargin. Exp Cell Res (1994) 1.37
CAML is required for efficient EGF receptor recycling. Dev Cell (2003) 1.34
Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice. J Immunol (1998) 1.29
BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc Natl Acad Sci U S A (2008) 1.29
CAML is a p56Lck-interacting protein that is required for thymocyte development. Immunity (2005) 1.16
Co-localization of calcium-modulating cyclophilin ligand with intracellular calcium pools. J Biol Chem (1998) 1.07
CAML loss causes anaphase failure and chromosome missegregation. Cell Cycle (2009) 0.92
Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes. Blood (2009) 0.92
Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI. Clin Vaccine Immunol (2007) 0.82
BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med (2004) 4.41
TACI and BAFF-R mediate isotype switching in B cells. J Exp Med (2005) 3.31
BLyS and APRIL in rheumatoid arthritis. J Clin Invest (2005) 1.75
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood (2004) 1.71
Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood (2002) 1.70
Retracted Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu. Nat Med (2008) 1.63
TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol (2007) 1.56
The anticancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism. FASEB J (2012) 1.42
CAML is required for efficient EGF receptor recycling. Dev Cell (2003) 1.34
Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue. Cancer Res (2007) 1.20
TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens. J Immunol (2007) 1.20
CAML is a p56Lck-interacting protein that is required for thymocyte development. Immunity (2005) 1.16
Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. Am J Physiol Renal Physiol (2006) 1.12
Severe osteogenesis imperfecta in cyclophilin B-deficient mice. PLoS Genet (2009) 1.12
Selective activation of TACI by syndecan-2. Blood (2005) 1.09
TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo. Blood (2005) 1.09
Calcium-modulating cyclophilin ligand regulates membrane trafficking of postsynaptic GABA(A) receptors. Mol Cell Neurosci (2008) 1.05
Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL. J Immunol (2008) 1.02
Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI. J Clin Invest (2011) 1.01
TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow. Blood (2011) 1.00
Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells. J Allergy Clin Immunol (2009) 0.98
CAML loss causes anaphase failure and chromosome missegregation. Cell Cycle (2009) 0.92
Fibrocystin interacts with CAML, a protein involved in Ca2+ signaling. Biochem Biophys Res Commun (2005) 0.90
Cyclophilin B supports Myc and mutant p53-dependent survival of glioblastoma multiforme cells. Cancer Res (2013) 0.86
HIV-1 Rev-binding protein accelerates cellular uptake of iron to drive Notch-induced T cell leukemogenesis in mice. J Clin Invest (2010) 0.84
Conditional deletion of calcium-modulating cyclophilin ligand causes deafness in mice. Mamm Genome (2011) 0.83
Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS). Biol Direct (2011) 0.82
Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice. J Immunol (2014) 0.81
Efficient B cell responses to Borrelia hermsii infection depend on BAFF and BAFFR but not TACI. Infect Immun (2013) 0.81
Knockin approaches. Methods Mol Biol (2003) 0.81
BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies. J Rheumatol (2013) 0.78
Tail-anchored protein insertion in mammals. FUNCTION AND RECIPROCAL INTERACTIONS OF THE TWO SUBUNITS OF THE TRC40 RECEPTOR. J Biol Chem (2016) 0.76
TBK1 suppression of IgA in the NIK of time. Nat Immunol (2012) 0.75
Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat). J Biol Chem (2012) 0.75
Protons: moving therapy for hodgkin lymphoma in a positive direction. Oncology (Williston Park) (2012) 0.75